A 33-year-old white woman arrived at the hospital to undergo a hysterectomy due to uterine fibroids. Blood smear review identified macrothrombocytopenia and Döhle body-like cytoplasmic leukocyte inclusions. Genetic testing identified a mutation in exon 39 of the myosin heavy chain gene (MHY9; OMIM 160775), which confirmed the diagnosis of May-Hegglin anomaly. May-Hegglin anomaly is one of a spectrum of MYH9 disorders that also includes Sebastian, Epstein, and Fechtner syndromes. Herein, we describe the clinical and laboratory presentation of a patient with May-Hegglin anomaly and provide an update on the molecular findings and a discussion of the genotypic-phenotypic correlations in this potentially underdiagnosed disorder.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985776 | PMC |
http://dx.doi.org/10.1093/labmed/lmw033 | DOI Listing |
SAGE Open Med Case Rep
December 2024
[This corrects the article DOI: 10.1177/2050313X241302013.].
View Article and Find Full Text PDFSAGE Open Med Case Rep
November 2024
Division of Nephrology, Hypertension and Transplant Nephrology, University of California, Irvine, CA, USA.
May-Hegglin anomaly (MHA) is a rare autosomal dominant disease associated with a mutation in the MYH-9 gene. It is characterized by macrothrombocytopenia and neutrophils with abnormal cytoplasmic inclusions. Clinical features of this disease include hearing loss, early cataracts, and renal failure.
View Article and Find Full Text PDFInt J Mol Sci
August 2024
Department of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, Cincinnati, OH 45229, USA.
Non-muscle myosin IIA (NM IIA) is a motor protein that belongs to the myosin II family. The myosin heavy chain 9 () gene encodes the heavy chain of NM IIA. NM IIA is a hexamer and contains three pairs of peptides, which include the dimer of heavy chains, essential light chains, and regulatory light chains.
View Article and Find Full Text PDFBMC Med Genomics
July 2024
Department of Pharmacology, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.
Background: Wilson disease (WD) is an autosomal recessive disorder caused by homozygous or compound heterozygous mutations in ATP7B. Clinical manifestations primarily involve liver and nervous system lesions, with rarely observed hematologic manifestations.
Case Presentation: In the present case, a patient with WD presented with thrombocytopenia, giant platelets, and Döhle-like cytoplasmic inclusions in the leukocytes.
Pediatr Blood Cancer
September 2024
Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Alberta, Edmonton, Canada.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!